Guardian Pharmacy Services (NYSE:GRDN) Trading Down 5.5% - Should You Sell?

Key Points

• Guardian Pharmacy Services shares fell 5.5% to about $39.19, with trading volume 69% below the average daily level.
• Analyst sentiment remains favorable: seven analysts rate the stock Buy and two rate it Hold, producing a “Moderate Buy” consensus and an average price target of $43.83. Truist and Oppenheimer recently raised their targets to $47 and $49, respectively.
• The company exceeded quarterly expectations, reporting $0.29 in earnings per share versus the $0.26 consensus and revenue of $351.77 million versus $340.45 million expected. Several institutional investors also increased their positions.

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report)'s stock price traded down 5.5% on Tuesday . The company traded as low as $39.54 and last traded at $39.1860. 121,588 shares changed hands during trading, a decline of 69% from the average daily volume of 388,726 shares. The stock had previously closed at $41.47.

Analysts Set New Price Targets

A number of analysts have issued reports on GRDN shares. Wall Street Zen raised Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a research report on Sunday. Zacks Research cut Guardian Pharmacy Services from a "strong-buy" rating to a "hold" rating in a research note on Monday, May 11th. Truist Financial increased their target price on Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a "buy" rating in a research note on Wednesday, June 17th. Weiss Ratings raised Guardian Pharmacy Services from a "hold (c)" rating to a "hold (c+)" rating in a research report on Thursday. Finally, Oppenheimer boosted their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an "outperform" rating in a research note on Friday. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Guardian Pharmacy Services presently has an average rating of "Moderate Buy" and an average target price of $43.83.

Guardian Pharmacy Services Trading Down 4.3%

The firm's fifty day simple moving average is $40.96 and its 200 day simple moving average is $37.25. The company has a market cap of $1.98 billion, a price-to-earnings ratio of 38.55, a PEG ratio of 2.87 and a beta of 0.11.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.26 by $0.03. The company had revenue of $351.77 million for the quarter, compared to analysts' expectations of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. As a group, sell-side analysts expect that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Great Lakes Advisors LLC purchased a new stake in Guardian Pharmacy Services during the 2nd quarter valued at approximately $788,000. Handelsbanken Fonder AB acquired a new position in shares of Guardian Pharmacy Services in the second quarter valued at approximately $511,000. Bank of America Corp DE increased its holdings in shares of Guardian Pharmacy Services by 86.1% in the first quarter. Bank of America Corp DE now owns 128,048 shares of the company's stock valued at $4,822,000 after purchasing an additional 59,245 shares during the period. The Manufacturers Life Insurance Company raised its stake in shares of Guardian Pharmacy Services by 67.4% during the first quarter. The Manufacturers Life Insurance Company now owns 11,820 shares of the company's stock worth $445,000 after purchasing an additional 4,761 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of Guardian Pharmacy Services by 79.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 38,185 shares of the company's stock worth $1,438,000 after purchasing an additional 16,866 shares during the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source